BRAF-V600E-mutated cell lines are solely dependent on RAF/MEK/ERK signaling for survival and this oncogene addiction makes RAF/MEK inhibitors relevant compounds for treatment of cancer [46]. This evidence concerns the gene MAPK1 and cancer.